KOWA VX-10I

K062021 · Kowa Co. , Ltd. · HKI · Nov 1, 2006 · Ophthalmic

Device Facts

Record IDK062021
Device NameKOWA VX-10I
ApplicantKowa Co. , Ltd.
Product CodeHKI · Ophthalmic
Decision DateNov 1, 2006
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 886.1120
Device ClassClass 2

Intended Use

KOWA VX -10i is intended for taking pictures of fundus images with mydriatic or without mydriatic.

Device Story

Kowa VX-10i is an ophthalmic camera used by eye care professionals in clinical settings to capture fundus images. The device functions by illuminating the retina and capturing high-resolution images of the fundus, which can be performed with or without pupil dilation (mydriatic). The captured images are displayed to the clinician to assist in the visual examination and documentation of ocular health. By providing clear, detailed imagery of the posterior segment of the eye, the device aids in the diagnosis and monitoring of various retinal conditions, facilitating clinical decision-making and patient management.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Ophthalmic camera system; optical imaging assembly for fundus visualization; supports mydriatic and non-mydriatic operation; Class II device (21 CFR 886.1120).

Indications for Use

Indicated for capturing fundus images in patients, with or without the use of mydriatic agents.

Regulatory Classification

Identification

An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.

Special Controls

*Classification.* Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure with three lines representing the body and head, and three curved lines representing the legs. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Kowa Co. Ltd. c/o Richard Phillips, Ph.D. Quintiles Consulting, Inc. 1801 Rockville Pike, Suite 300 Rockville, MD 20852 NOV 0 1 2006 Re: K062021 Trade/Device Name: Kowa VX-10i Fundus Camera Regulation Number: 21 CFR 886.1120 Regulation Name: Ophthalmic Camera Regulatory Class: II Product Code: HKI Dated: October 23, 2006 Received: October 23, 2006 Dear Dr. Phillips: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ ## Page 2 - Richard Phillips, Ph.D. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, M.B. Egbert Simund Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________ Device Name: KOWA VX-10i Indications For Use: KOWA VX -10i is intended for taking pictures of fundus images with mydriatic or without mydriatic. Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Marsha L. Burke Nicholas Division Sion-Off Division of Ophthalmic Ear, Nose and Throat Devises KO62021 510(k) Number __ Page 1 of ____________________________________________________________________________________________________________________________________________________________________
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...